Both in Pharmaceuticals
Kiniksa Pharmaceuticals International vs Alkermes
Over the past year KNSA returned +152.4% and ALKS returned +50.9%; their daily moves had a correlation of 0.12.
KNSA +152.4% ALKS +50.9%Growth of $1, one year, split-adjusted
| Metric | KNSA | ALKS |
|---|---|---|
| Price | $94.56 | $45.52 |
| Market cap | $7.43B | $7.64B |
| Today | +1.36% | −0.38% |
| 1 month | +22.7% | +9.3% |
| 6 months | +62.4% | +28.9% |
| Year to date | +129.2% | +62.7% |
| 1 year | +152.4% | +50.9% |
| Revenue growth (YoY) | +58.1% | +21.8% |
| Gross margin | 90.3% | 80.4% |
| Net margin | 16.6% | 3.4% |
| P/E (TTM) | 67.8× | — |
| Price / sales | 7.9× | 4.4× |
| Net cash | $462.9M | -$742.3M |
| Dividend yield | — | — |
| Volatility (60d) | 54.0% | 31.7% |
| Short % of float | 9.6% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).